Evidence map›Paper›PMID 27507714›Full record

ArticleNature communications2016

MEF2C protects bone marrow B-lymphoid progenitors during stress haematopoiesis.

Wenyuan Wang, Tonis Org, Amélie Montel-Hagen, Peter D Pioli, Dan Duan, Edo Israely, Daniel Malkin, Trent Su, Johanna Flach, Siavash K Kurdistani and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Wenyuan WangDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California 90095, USA.
Tonis OrgDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California 90095, USA.
Amélie Montel-HagenDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California 90095, USA.
Peter D PioliDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California 90095, USA.
Dan DuanDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California 90095, USA.
Edo IsraelyDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California 90095, USA.
Daniel MalkinDepartment of Molecular Toxicology, UCLA, Los Angeles, California 90095, USA.
Trent SuDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Johanna FlachThe Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California San Francisco, San Francisco, California 94143, USA.
Siavash K KurdistaniDepartment of Biological Chemistry, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA.
Robert H SchiestlDepartment of Molecular Toxicology, UCLA, Los Angeles, California 90095, USA.
Hanna K A MikkolaDepartment of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California 90095, USA.
University of California, Los Angeles · USBroad Center · USUCLA Jonsson Comprehensive Cancer Center

Funding

UCLA Center for Biological RadioprotectorsU19AI067769 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MCBRIDE, WILLIAM H. · 2005 to 2019
$44.6M
TUMOR CELL SURFACES AND CHROMOSOMEST32CA009056 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Gay M Crooks, David A. Nathanson · 1985 to 2026
$10.5M
Training in Molecular ToxicologyT32ES015457 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALLARD, PATRICK, HANKINSON, OLIVER NMN · 2008 to 2025
$4.0M
Dynamics of Histone Acetylation in Cancer Cell PhysiologyR01CA178415 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KURDISTANI, SIAVASH · 2013 to 2017
$1.6M
Mef2C as a regulator of DNA repair and aging in the B-lymphoid systemR21AG050278 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MIKKOLA, HANNA KATRI ANNIKKI · 2015 to 2016
$415k
NCI NIH HHS R01 CA178415NCI NIH HHS T32 CA009056NIAID NIH HHS U19 AI067769NIA NIH HHS R21 AG050278NIEHS NIH HHS T32 ES015457
6 · The paper itself

Abstract

DNA double strand break (DSB) repair is critical for generation of B-cell receptors, which are pre-requisite for B-cell progenitor survival. However, the transcription factors that promote DSB repair in B cells are not known. Here we show that MEF2C enhances the expression of DNA repair and recombination factors in B-cell progenitors, promoting DSB repair, V(D)J recombination and cell survival. Although Mef2c-deficient mice maintain relatively intact peripheral B-lymphoid cellularity during homeostasis, they exhibit poor B-lymphoid recovery after sub-lethal irradiation and 5-fluorouracil injection. MEF2C binds active regulatory regions with high-chromatin accessibility in DNA repair and V(D)J genes in both mouse B-cell progenitors and human B lymphoblasts. Loss of Mef2c in pre-B cells reduces chromatin accessibility in multiple regulatory regions of the MEF2C-activated genes. MEF2C therefore protects B lymphopoiesis during stress by ensuring proper expression of genes that encode DNA repair and B-cell factors.

Indexed as

DNA Breaks, Double-StrandedAnimalsCell SurvivalChromatinFemaleFluorouracilHematopoiesisMaleMEF2 Transcription FactorsMicePrecursor Cells, B-LymphoidV(D)J RecombinationWhole-Body IrradiationChromatinFluorouracilMef2c protein, mouseMEF2 Transcription Factors

Identifiers

PMID27507714
PMCPMC4987520
OpenAlexW2479754410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.